Fig. 3.
Fig. 3. Case 17. / Phenotypic expression (A), redirected cytotoxicity against P-815 target cells (B), and proliferative activity (C) in the presence of mAbs to CD30, CD30L, CD40, CD40L, CD70, CD95, and CD95L in a representative CD3− patient (case 17). The experimental conditions were the same as in Figure 1.

Case 17.

Phenotypic expression (A), redirected cytotoxicity against P-815 target cells (B), and proliferative activity (C) in the presence of mAbs to CD30, CD30L, CD40, CD40L, CD70, CD95, and CD95L in a representative CD3− patient (case 17). The experimental conditions were the same as in Figure 1.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal